These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characteristics of de la Fouchardière C; Cohen R; Malka D; Guimbaud R; Bourien H; Lièvre A; Cacheux W; Artru P; François E; Gilabert M; Samalin-Scalzi E; Zaanan A; Hautefeuille V; Rousseau B; Senellart H; Coriat R; Flippot R; Desseigne F; Lardy-Cleaud A; Tougeron D Oncologist; 2019 Dec; 24(12):e1331-e1340. PubMed ID: 31152084 [TBL] [Abstract][Full Text] [Related]
6. BRAF Grillo F; Paudice M; Pigozzi S; Dono M; Lastraioli S; Lugaresi M; Bozzano S; Tognoni C; Ali M; Sciallero S; Puccini A; Fassan M; Mastracci L Histopathology; 2024 Apr; 84(5):877-887. PubMed ID: 38173291 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer. Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219 [TBL] [Abstract][Full Text] [Related]
8. Somatic BRAF-V600E mutations in familial colorectal cancer. Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056 [TBL] [Abstract][Full Text] [Related]
9. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages. Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517 [TBL] [Abstract][Full Text] [Related]
11. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358 [TBL] [Abstract][Full Text] [Related]
12. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancer. Aparicio T; Schischmanoff O; Poupardin C; Mary F; Soufir N; Barrat C; Bellaiche G; Boubaya M; Choudat L; Cucherousset J; DesGuetz G; Wind P; Benamouzig R J Geriatr Oncol; 2014 Oct; 5(4):384-8. PubMed ID: 25176643 [TBL] [Abstract][Full Text] [Related]
14. Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study. Gkekas I; Jan N; Kaprio T; Beilmann-Lehtonen I; Fabian P; Tavelin B; Böckelman C; Edin S; Strigård K; Svoboda T; Hagström J; Barsova L; Jirasek T; Haglund C; Palmqvist R; Gunnarsson U J Surg Oncol; 2024 Jun; 129(7):1295-1304. PubMed ID: 38470492 [TBL] [Abstract][Full Text] [Related]
15. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. Di Nicolantonio F; Martini M; Molinari F; Sartore-Bianchi A; Arena S; Saletti P; De Dosso S; Mazzucchelli L; Frattini M; Siena S; Bardelli A J Clin Oncol; 2008 Dec; 26(35):5705-12. PubMed ID: 19001320 [TBL] [Abstract][Full Text] [Related]
16. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
17. Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer. Yukimoto R; Nishida N; Hata T; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Satoh T; Hirofumi Y; Mizushima T; Doki Y; Eguchi H Cancer Sci; 2021 Jul; 112(7):2884-2894. PubMed ID: 33934428 [TBL] [Abstract][Full Text] [Related]
18. Analysis of DNA mismatch repair proteins expression and BRAF V600E mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico. Luévano-González A; Guzmán AQ; Ancer Rodríguez J; Ortiz López R; Rojas Martínez A; González Guerrero JF; Flores Gutiérrez JP Arch Med Res; 2011 Aug; 42(6):457-62. PubMed ID: 21945875 [TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan. Ikoma T; Shimokawa M; Kotaka M; Matsumoto T; Nagai H; Boku S; Shibata N; Yasui H; Satake H BMC Cancer; 2021 May; 21(1):518. PubMed ID: 33962575 [TBL] [Abstract][Full Text] [Related]
20. BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Phipps AI; Buchanan DD; Makar KW; Burnett-Hartman AN; Coghill AE; Passarelli MN; Baron JA; Ahnen DJ; Win AK; Potter JD; Newcomb PA Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1792-8. PubMed ID: 22899730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]